MDPI and ACS Style
Na, Y.-J.; Choi, K.J.; Jung, W.H.; Park, S.B.; Kang, S.; Ahn, J.H.; Kim, K.Y.
A Novel Selective 11β-HSD1 Inhibitor, (E)-4-(2-(6-(2,6-Dichloro-4-(Trifluoromethyl)Phenyl)-4-Methyl-1,1-Dioxido-1,2,6-Thiadiazinan-2-yl)Acetamido)Adamantan-1-Carboxamide (KR-67607), Prevents BAC-Induced Dry Eye Syndrome. Int. J. Mol. Sci. 2020, 21, 3729.
https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21103729
AMA Style
Na Y-J, Choi KJ, Jung WH, Park SB, Kang S, Ahn JH, Kim KY.
A Novel Selective 11β-HSD1 Inhibitor, (E)-4-(2-(6-(2,6-Dichloro-4-(Trifluoromethyl)Phenyl)-4-Methyl-1,1-Dioxido-1,2,6-Thiadiazinan-2-yl)Acetamido)Adamantan-1-Carboxamide (KR-67607), Prevents BAC-Induced Dry Eye Syndrome. International Journal of Molecular Sciences. 2020; 21(10):3729.
https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21103729
Chicago/Turabian Style
Na, Yoon-Ju, Kyoung Jin Choi, Won Hoon Jung, Sung Bum Park, Sein Kang, Jin Hee Ahn, and Ki Young Kim.
2020. "A Novel Selective 11β-HSD1 Inhibitor, (E)-4-(2-(6-(2,6-Dichloro-4-(Trifluoromethyl)Phenyl)-4-Methyl-1,1-Dioxido-1,2,6-Thiadiazinan-2-yl)Acetamido)Adamantan-1-Carboxamide (KR-67607), Prevents BAC-Induced Dry Eye Syndrome" International Journal of Molecular Sciences 21, no. 10: 3729.
https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21103729